Acceptance and Commitment Therapy in Tuberous Sclerosis Complex (ACT in TSC)
Tuberous Sclerosis Complex
About this trial
This is an interventional treatment trial for Tuberous Sclerosis Complex focused on measuring Tuberous Sclerosis Complex, Acceptance and Commitment Therapy, Mental Health, Psychology, Paediatrics, Neurology, Remote therapy, TAND
Eligibility Criteria
Inclusion Criteria: Aged 11 to 24 years. Diagnosis of Tuberous Sclerosis Complex. Sufficient understanding of English to engage with the intervention (spoken and written), as judged by the assessing clinician. Sufficient cognitive, sensory and speech capabilities to take part in the intervention. Participants (or their parents if under 16) give verbal or written informed consent to participate in the study. Participants give verbal or written assent if under 16. Receiving treatment over video-conferencing will be the default modality for delivery, so access to the internet is a requirement. Exclusion Criteria: Previous structured behavioural intervention within last 6 months. Previous or current alcohol/substance dependence, psychosis, suicidality, or anorexia nervosa. Moderate or severe intellectual disability. Immediate risk to self or others. Parent or child not able to speak, read or write English.
Sites / Locations
- University Hospitals Bristol and Weston NHS TrustRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Allocated to treatment
Allocated to waitlist control
Patients randomly allocated to this arm will receive treatment immediately. They will receive 6-12 sessions of ACT while patients allocated to the waitlist control arm do no receive any treatment.
Patients randomly allocated to this arm will receive a delay in the treatment they receive. After a 12-week wait they will receive 6-12 sessions of ACT, while patients allocated to the immediate treatment arm receive no treatment for an equal duration.